US 10221243
Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10221243 (Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)) held by Five Prime Therapeutics, Inc. expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P